8-KThe WireRoutine
Company Update
Filed Sep 11, 2024 · 1y ago · Accession 0001140361-24-040755
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- BridgeBio Pharma, Inc.
- Ticker
- BBIO
- CIK
- 1743881
- Form type
- 8-K
- Filing date
- Sep 11, 2024
- Report date
- Sep 10, 2024
- Document
- ef20035749_8k.htm
- Size
- 190 KB